Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-28 to 2025-01-29
Current total value of award: $2683.84
Description: 4567071069!QUILLIVANT XR 25 MG/5 ML SUSP 120ML